Efficacy of bedaquiline in the treatment of drug-resistant tuberculosis: a systematic review and meta-analysis

BACKGROUND: Drug-resistant tuberculosis (DR-TB) remains a major public health concern worldwide. Bedaquiline, a novel diarylquinoline, was added to the WHO-recommended all-oral regimen for patients with multidrug-resistant tuberculosis. We performed a systematic review and meta-analysis to determine...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ming-Gui, Wu, Shou-Quan, He, Jian-Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447831/
https://www.ncbi.nlm.nih.gov/pubmed/34535090
http://dx.doi.org/10.1186/s12879-021-06666-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447831/
https://www.ncbi.nlm.nih.gov/pubmed/34535090
http://dx.doi.org/10.1186/s12879-021-06666-8

Ejemplares similares